Labgenomics Co Interest Coverage
The Interest Coverage Ratio of Labgenomics Co (084650.KQ) as of Sep 21, 2026 is -3.58. In the previous year, Interest Coverage Ratio was -4.37 — a change of -18.21% (higher).
Get this data via API
Financial Data API
Interest Coverage
-3.58
YoY
-18.21%
Last updated:
The Labgenomics Co Interest Coverage history
3 Years
10 Years
25 Years
Max
| YEAR | Interest Coverage | YoY |
|---|---|---|
| -3.58 | -18.21% | |
| -4.37 | -120.32% | |
| 21.52 | -11.61% | |
| 24.34 | -27.25% | |
| 33.46 | +572.84% | |
| 4.97 | -149.65% | |
| -10.02 | -2.14% | |
| -10.23 | +1,951.46% | |
| -0.50 | -100.34% | |
| 147.48 | +768.10% | |
| 16.99 | — |
Labgenomics Co Stock analysis
Frequently Asked Questions about Labgenomics Co stock
Interest Coverage Ratio of Labgenomics Co is -3.58 in 2026.
Interest Coverage Ratio of Labgenomics Co changed from -4.37 to -3.58, representing a -18.21% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Interest Coverage Ratio Labgenomics Co since 2006 – with annual values, charts, and detailed analysis.
The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.
Interest Coverage = EBIT / Interest Expense
A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Labgenomics Co with sector peers and the industry average to assess whether it is attractive.
Leverage — Labgenomics Co
All Key Metrics — Labgenomics Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth